How do sweat-inducing hot flashes, muffin-top expansion, lethargy and insomnia sound? The aforementioned doesn’t sound too appealing, however, to many women, this is the reality of the oft-abhorred “midlife transition.” But, many of these side effects can be remedied. Many women find this transition to be fulfilling, a chance to start out on a new adventure and seize the day, so to speak. At Sound Sleep Institute, we have a deep-seated passion for sleep. Sleep hygiene, we understand, is considered to be taboo by many in the fast paced world we live in. But there does come a point in all of our lives in which we must assess the importance of our sleep routine, and for those going through menopause, what better time? Don’t let menopause cause upheaval in your life and rob you of the restorative sleep you need.
Hormone fluctuations are the culprit to those pesky hot flashes. Hot flashes and night sweats can wake you out of a peaceful sleep, only to leave you lying there in bed unable to nod back to your slumber. According to a 2007 National Sleep Foundation survey, nearly half of women between the ages of 45 and 64 say they have trouble sleeping. The good news is that those reprehensible hot flashes can be held in check. A mixture of herbs and supplements, exercise and dietary changes can have you sleeping like you did before, if not better than when menopause began.
Asthma is a prevalent disease among children, accounting for numerous emergency room visits, and unfortunately, a significant cause of morbidity. Although asthma incidence has increased over the past few decades, variations between countries, environmental factors and the use of certain medications have created a flurry of research dedicated to the disease and the understanding of its etiology.
Epidemiological studies have suggested that they key time period for childhood allergies and asthma development occurs between conception and early childhood, and prenatal drug use has also been implicated. In a letter to the Editor in The Journal of Allergy & Clinical Immunology, Mulder and colleagues assessed the association between the use of acid-suppressive drugs during pregnancy and the risk of developing childhood asthma using a crossover study. As gastrointestinal symptoms in pregnancy are fairly common, proton pump inhibitors (PPIs), histamine 2 receptor antagonists (H2ra) and other antacids have been known to be effective. Understanding that the development of asthma is a complex interaction between genetic and environmental factors, researchers used a general practitioners research database to identify children with a drug-treated asthma diagnosis between the years 2006 and 2010 that were matched with a sibling without asthma. Researchers conducted analyses based on exposure of anti-suppressive drugs, drug class (e.g. PPIs, H2ra) and trimester.
Of the 3,748 children studied, half with asthma and the other used as a control group, 22% of the children with asthma had mothers who were exposed to an acid-suppressive drug during their pregnancy compared to 20% in the control group. This data suggests that exposure to acid-suppressive drugs during pregnancy presents an increased chance in developing childhood asthma. Upon further analyses, mothers who used acid-suppressive drugs during the third trimester increased the odds of their child developing childhood asthma. These findings support evidence that exposure to acid-suppressive drugs during pregnancy is associated with childhood asthma. Although more research is needed to understand the exact mechanisms, one hypothesis suggests that neutralized gastric levels prevent adequate digestion of antigens in the mother’s stomach. The antigens, if not degraded can create sensitization of the immune system and cross the placenta creating likelihood for allergic sensitization of the fetus.